Charles A. Reinhart, III, serves as the Chief Financial Officer (CFO) at Pacira BioSciences, Inc., a specialty pharmaceutical company focused on developing, commercializing, and manufacturing innovative products that improve patient outcomes and reduce healthcare costs. In his role as CFO, Reinhart oversees all financial aspects of the company, including financial planning and analysis, accounting, investor relations, and treasury management. He plays a crucial role in shaping the company's strategic direction and ensuring its financial health and growth. Reinhart brings extensive experience in the pharmaceutical and biotechnology industries to his position at Pacira BioSciences. Prior to joining the company, he served as CFO at OptiNose, Inc., where he was instrumental in leading the company through its initial public offering (IPO) and subsequent growth phases. Before OptiNose, Reinhart held various senior financial positions at companies such as Auxilium Pharmaceuticals, Inc., and Sepracor, Inc. His expertise in financial strategy, capital markets, and mergers and acquisitions has been pivotal in driving the success of the organizations he has worked with. Throughout his career, Reinhart has demonstrated a strong ability to navigate complex financial landscapes and deliver sustainable growth. At Pacira BioSciences, he has been instrumental in strengthening the company's financial position, optimizing its capital structure, and supporting the launch and expansion of key products such as EXPAREL, a non-opioid pain management solution. His leadership and strategic vision continue to be vital assets as Pacira BioSciences strives to innovate and expand its portfolio of life-changing therapies.